JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1994) 142, 277-283       DOI: 10.1677/joe.0.1420277
© 1994 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gibb, C A
Right arrow Articles by Conigrave, A D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gibb, C A
Right arrow Articles by Conigrave, A D

Pharmacological characterization of the nucleotide receptors that mobilize Ca2+ ions in human parathyroid cells

C A Gibb, D I Cook, L Delbridge and A D Conigrave

We have used the fluorescent probe fura-2 to perform agonist studies of the receptor(s) that mobilizes Ca2+ ions in response to extracellular ATP in human parathyroid cells. Extracellular ATP induced Ca2+ responses in both normal and adenomatous parathyroid cells. Activation resulted in an initial small transient response during which Ca2+ ions were released from intracellular stores, followed by a prominent plateau response during which Ca2+ ions entered the cells from the extracellular fluid. The responses exhibited moderate desensitization upon repeated stimulation with ATP, and the ratio of the plateau to the peak response remained constant for any given group of activated cells. The baseline intracellular calcium concentration was 100 ± 4·3 nM (mean ± S.E.M., n=3). Following maximal activation by extracellular ATP it rose to a peak of 684 ± 45·7 nM (n=3) and a plateau level of 415 ± 9·9 nM (n=3).

We examined the effects of a variety of nucleotide species. The order of potency was: adenosine, AMP<{alpha},β-methylene ATP<ADP<ATP{approx}UTP. In the concentration range 1–1000 µM, UTP (the concentration of agonist inducing a half-maximal response, EC50=2·4 µM) was slightly more potent than ATP EC50=3·6 µM), and the two nucleotides evoked similar maximal responses. In the concentration range 0·01–1·0 µM, however, there was a clear difference in the behaviour of the two nucleotides. In particular, ATP, but not UTP, evoked responses that suggested the presence of a second receptor of higher potency but markedly lower efficacy. Responses to 2-methylthioATP (2-MeSATP) in the concentration range 0·01–100 µM defined a dose–response curve that matched the lower concentration component of the ATP dose–response curve.

Together, these data suggest that two receptor species are involved in the Ca2+ responses. One is a nucleotide/P2U receptor that responds to ATP and UTP, which are approximately equipotent agonists; 2-MeSATP is only a weak agonist with respect to this receptor. The other belongs to the P2Y receptor subclass. It responds to 2-MeSATP, a selective agonist at P2Y receptors, and to ATP, but not to the pyrimidine nucleotide UTP.

Journal of Endocrinology (1994) 142, 277–283







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the Society for Endocrinology.